1. Home
  2. EM vs TVGN Comparison

EM vs TVGN Comparison

Compare EM & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smart Share Global Limited

EM

Smart Share Global Limited

HOLD

Current Price

$1.13

Market Cap

339.8M

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$0.33

Market Cap

89.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
EM
TVGN
Founded
2017
2020
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Blank Checks
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
339.8M
89.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
EM
TVGN
Price
$1.13
$0.33
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$1.25
$5.00
AVG Volume (30 Days)
859.1K
1.4M
Earning Date
03-27-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$259,541,587.00
N/A
Revenue This Year
$3.30
N/A
Revenue Next Year
$5.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.30
52 Week High
$1.46
$1.92

Technical Indicators

Market Signals
Indicator
EM
TVGN
Relative Strength Index (RSI) 22.36 32.95
Support Level $1.18 $0.30
Resistance Level $1.22 $0.41
Average True Range (ATR) 0.04 0.03
MACD -0.02 -0.00
Stochastic Oscillator 8.00 23.04

Price Performance

Historical Comparison
EM
TVGN

About EM Smart Share Global Limited

Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: